C07D 211/48
Having an acyclic carbon atom attached in position 4
Official title: having an acyclic carbon atom attached in position 4
C07D211/48 (Having an acyclic carbon atom attached in position 4) appears on 204 US grants and 166 published applications in this corpus.
Search patents in C07D- Granted patents
- 204
- Published applications
- 166
- Assignees
- 126
- Inventors
- 723
- Latest grant
- 2 Dec 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1977 | 4 | 0 |
| 1978 | 2 | 0 |
| 1979 | 3 | 0 |
| 1980 | 1 | 0 |
| 1981 | 5 | 0 |
| 1982 | 4 | 0 |
| 1983 | 5 | 0 |
| 1984 | 3 | 0 |
| 1985 | 3 | 0 |
| 1986 | 4 | 0 |
| 1987 | 3 | 0 |
| 1988 | 5 | 0 |
| 1989 | 2 | 0 |
| 1990 | 1 | 0 |
| 1991 | 3 | 0 |
| 1992 | 2 | 0 |
| 1993 | 3 | 0 |
| 1994 | 5 | 0 |
| 1995 | 5 | 0 |
| 1996 | 6 | 0 |
| 1997 | 6 | 0 |
| 1998 | 3 | 0 |
| 1999 | 2 | 0 |
| 2000 | 3 | 0 |
| 2001 | 1 | 2 |
| 2002 | 3 | 4 |
| 2003 | 5 | 3 |
| 2004 | 2 | 10 |
| 2005 | 5 | 8 |
| 2006 | 2 | 17 |
| 2007 | 4 | 11 |
| 2008 | 4 | 8 |
| 2009 | 11 | 4 |
| 2010 | 6 | 9 |
| 2011 | 5 | 7 |
| 2012 | 7 | 5 |
| 2013 | 6 | 6 |
| 2014 | 7 | 10 |
| 2015 | 11 | 10 |
| 2016 | 6 | 6 |
| 2017 | 11 | 8 |
| 2018 | 5 | 8 |
| 2019 | 6 | 2 |
| 2020 | 4 | 2 |
| 2021 | 1 | 3 |
| 2022 | 3 | 5 |
| 2023 | 0 | 3 |
| 2024 | 2 | 5 |
| 2025 | 4 | 6 |
| 2026 | 0 | 4 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Compounds2 Dec 2025US 12,485,169 B2Grey Wolf Therapeutics Limited
- Dopamine D2 receptor ligands30 Sep 2025US 12,428,373 B2Massachusetts Institute of Technology
- WDR5-MYC inhibitors26 Aug 2025US 12,398,097 B2Vanderbilt University
- Fatty acid analogues and methods of use25 Mar 2025US 12,258,324 B2
- Compositions for treating neurodegenerative diseases14 May 2024US 11,981,636 B2Cognition Therapeutics, Inc.
- Lsd1 modulators23 Jul 2026US 2026/0209214 A1Recursion Pharmaceuticals, Inc.
- Erap1 modulating compounds16 Jul 2026US 2026/0199455 A1Grey Wolf Therapeutics Limited
- Dihydroindene derivatives as malt1 inhibitors2 Jul 2026US 2026/0184687 A1C4X Discovery Limited
- Compounds for the Treatment of Neurodegenerative Diseases22 Jan 2026US 2026/0022094 A1Celgene Corporation
- Piperazine derivative or salt thereof, and pharmaceutical composition23 Oct 2025US 2025/0326744 A1FUJIFILM Corporation
Most cited
By later US patents
- Urea derivatives and their use as ACAT inhibitors134US 5,621,010 ANisshin Flour Milling Co., Ltd. · 1997
- Apoptosis promoters88US 7,767,684 B2Abbott Laboratories · 2010
- Biphenyl derivatives85US 7,141,671 B2Theravance, Inc. · 2006
- Therapeutic ureas81US 6,635,764 B2Theravance, Inc. · 2003
- Arylalkylamines, process for preparing them and pharmaceutical compositions containing them70US 5,236,921 ASanofi · 1993